Medical Condition News

RSS

D-ribose effective in improving QOL in energy-depleted patients with FMS/CFS

A new multicenter study published in The Open Pain Journal showed that daily consumption of the pentose carbohydrate D-ribose resulted in an average energy boost of 61 percent among patients diagnosed with Chronic Fatigue Syndrome (CFS) and fibromyalgia (FMS).

17 Jul 2012

Stress management treatment reduces formation of new brain lesions in people with MS

Research conducted by Jesus Lovera, MD, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has shown that stress management treatment significantly reduced the formation of new brain lesions in people with multiple sclerosis (MS) over the course of treatment.

17 Jul 2012

New automated method for identification of lung nodules in community-based settings

Pulmonary nodules are common, but few studies of lung nodule identification and clinical evaluation have been performed in community settings. Researchers from Kaiser Permanente Southern California identified 7,112 patients who had one or more nodules by using existing information within the electronic medical record.

17 Jul 2012

InvivoSciences, WUSTL to construct artificial tissue models for heart failure

The National Institutes of Health has awarded more than $2 million to a team of scientists from Washington University in St. Louis and InvivoSciences, a biotechnology startup with WUSTL roots, to construct artificial tissue models that will allow the rapid testing of new drugs for heart failure.

17 Jul 2012

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Acute myeloid leukemia, a common leukemia in adults, is characterized by aberrant proliferation of cancerous bone marrow cells. Activating mutations in a protein receptor known as FLT3 receptor are among the most prevalent mutations observed in acute myeloid leukemias. FLT3 mutants are thought to activate several signaling pathways that contribute to cancer development.

17 Jul 2012

Osteoporosis and sarcopenia: researchers at UMKC receive $8.3 million to study relationship

The University of Missouri-Kansas City has received a five-year, $8.3 million grant from the National Institute on Aging, part of the National Institutes of Health, to study the relationship between osteoporosis (loss of bone density) and sarcopenia (loss of muscle mass) as people age.

16 Jul 2012

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the achievement of positive clinical results from its Phase I trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis.

16 Jul 2012

FDA clears TMI’s Glider PTCA balloon catheter

TriReme Medical, Inc. (TMI) announced today that it has received FDA clearance for an expanded matrix of sizes for its unique Glider PTCA balloon catheter.

16 Jul 2012

Merck to present results from clinical studies on BACE inhibitors at AAIC 2012

Merck, known as MSD outside the United States and Canada, announced today presentations at the upcoming Alzheimer's Association International Conference (AAIC) being held in Vancouver, British Columbia, Canada on July 14-19, 2012.

16 Jul 2012

St. Joseph Hospital initiates enrollment in Medtronic’s SYMPLICITY HTN-3 trial for hypertension

St. Joseph Hospital of Orange on July 11 enrolled its first patient as part of a national clinical trial conducted by Medtronic Inc. for a renal denervation procedure designed to eliminate treatment-resistant hypertension.

From Medtronic 16 Jul 2012

TV watching increases waist size and reduces sporting ability in children

Each hour of TV watched by a two- to four-year- old contributes to his or her waist circumference by the end of grade 4 and his or her ability to perform in sports, according to a world-first study undertaken by researchers at the University of Montreal and its affiliated Saint-Justine Mother and Child University Hospital.

16 Jul 2012

UMMS scientists identify new genetic mutation that causes familial ALS

A new genetic mutation that causes familial amyotrophic lateral sclerosis (ALS), a fatal neurological disorder also known as Lou Gehrig's Disease, has been identified by a team of scientists led by researchers at the University of Massachusetts Medical School (UMMS).

16 Jul 2012

UCB’s Neupro now available in U.S. pharmacies

UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptoms of early and advanced stage idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome.

16 Jul 2012

Study determines optimal screening strategy for gastric or stomach cancer

A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality.

16 Jul 2012

New surgical technique may repair common, painful hip condition in elite athletes

A common, painful hip condition in elite athletes may be able to be repaired with an improved surgical technique, according to researchers presenting their work at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Baltimore, Maryland today.

16 Jul 2012

Novel way to monitor real-time chemical changes in brains of patients undergoing DBS

Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use DBS to treat brain disorders such as Parkinson's disease, depression and Tourette syndrome.

16 Jul 2012

PRP therapy safe and effective method of treatment for athletes with cartilage tears

When it comes to treating cartilage tears in athletes, Platelet Rich Plasma (PRP) therapy is a safe and effective method of treatment, according to research presented today at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting in Baltimore.

16 Jul 2012

Patients undergoing repeat ACL surgery are unlikely to return to prior activity levels

Patients who undergo repeated anterior cruciate ligament (ACL) reconstructions, or repeat revision surgery, are unlikely to return to prior activity levels despite showing basic functional improvement according to research being presented at the American Orthopaedic Society for Sports Medicine's (AOSSM) Annual Meeting today.

16 Jul 2012

Gait disturbances could indicate a decline in cognitive function

Gait disturbances – such as a slowing of walking pace or a more variable stride – could indicate a decline in cognitive function, according to new research studies reported today at the Alzheimer's Association's International Conference 2012 (AAIC 2012).

16 Jul 2012

Studies describe ability of targeted exercise training on cognitive impairment and dementia

Four studies reported today at the Alzheimer's Association International Conference 2012 (AAIC 2012) describe the ability of targeted exercise training to promote improved mental functioning and reduced risk for cognitive impairment and dementia in cognitively healthy older adults and those with mild cognitive impairment (MCI).

16 Jul 2012

Medical Condition News

D-ribose effective in improving QOL in energy-depleted patients with FMS/CFS

Stress management treatment reduces formation of new brain lesions in people with MS

New automated method for identification of lung nodules in community-based settings

InvivoSciences, WUSTL to construct artificial tissue models for heart failure

Targeting CDK1 pathway may be efficacious for acute myeloid leukemias with FLT3 mutation

Osteoporosis and sarcopenia: researchers at UMKC receive $8.3 million to study relationship

Positive results from Alnylam’s ALN-TTR02 Phase I trial on TTR-mediated amyloidosis

FDA clears TMI’s Glider PTCA balloon catheter

Merck to present results from clinical studies on BACE inhibitors at AAIC 2012

St. Joseph Hospital initiates enrollment in Medtronic’s SYMPLICITY HTN-3 trial for hypertension

TV watching increases waist size and reduces sporting ability in children

UMMS scientists identify new genetic mutation that causes familial ALS

UCB’s Neupro now available in U.S. pharmacies

Study determines optimal screening strategy for gastric or stomach cancer

New surgical technique may repair common, painful hip condition in elite athletes

Novel way to monitor real-time chemical changes in brains of patients undergoing DBS

PRP therapy safe and effective method of treatment for athletes with cartilage tears

Patients undergoing repeat ACL surgery are unlikely to return to prior activity levels

Gait disturbances could indicate a decline in cognitive function

Studies describe ability of targeted exercise training on cognitive impairment and dementia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News